MaRS Innovation

MaRS Innovation
Name	MaRS Innovation
Formation	2008
Type	Technology transfer, commercialization
Headquarters	Toronto, Ontario, Canada
Region served	Ontario, Canada

MaRS Innovation is a Toronto-based technology commercialization entity that bridges academic research and industry to accelerate commercialization of scientific discoveries. It operates within a network of universities, hospitals, investors, and corporations to translate inventions into startup companies, licensed technologies, and clinical products. The organization draws on expertise from institutions across Ontario and engages with global partners in biotechnology, medical devices, cleantech, and information technology.

History

Founded in 2008, the organization emerged from collaboration among major Canadian research institutions such as University of Toronto, McMaster University, University of Ottawa, Western University, Queen's University, University of Waterloo, University of Guelph, and York University. Early initiatives aligned with provincial priorities set by the Government of Ontario and federal research policy led by Natural Sciences and Engineering Research Council of Canada and Canadian Institutes of Health Research. Founding stakeholders included healthcare institutions like The Hospital for Sick Children, Mount Sinai Hospital (Toronto), and St. Michael's Hospital (Toronto), alongside research networks including Ontario Centres of Excellence and innovation hubs like The MaRS Discovery District. Throughout its history the group has interacted with municipal actors such as City of Toronto, economic development agencies like Invest in Ontario, and national funding bodies including Innovation, Science and Economic Development Canada. Milestones include technology licensing agreements and spin-out formations collaborating with venture capital firms such as OMERS Ventures, Borealis Ventures, Wellington Partners and strategic investors like Johnson & Johnson Innovation. Engagement with international partners has included entities such as Bill & Melinda Gates Foundation, Wellcome Trust, and multinational corporations including Pfizer, Roche, Novartis, and Siemens.

Organization and Governance

The governance framework incorporates representatives from member institutions including University of Toronto Faculty of Medicine, Sunnybrook Health Sciences Centre, Toronto General Hospital Research Institute, and academic departments such as Department of Biochemistry (University of Toronto), drawing expertise from boards with members from firms like BlackBerry Limited, Shopify, RBC, Scotiabank, TD Bank Group, and BMO Financial Group. Executive leadership has engaged with thought leaders associated with Ontario Institute for Cancer Research, Princess Margaret Cancer Centre, Lunenfeld-Tanenbaum Research Institute, and technology transfer offices at Mount Sinai Hospital Research Institute. Advisory committees often include entrepreneurs and scientists linked to institutions such as Harvard Medical School, Stanford University School of Medicine, Massachusetts Institute of Technology, Cambridge University, Imperial College London, and industry partners like Medtronic, GE Healthcare, and Abbott Laboratories. Compliance and governance practices reference standards used by organizations including Canadian Innovation Exchange and boards influenced by corporate governance frameworks similar to those at Suncor Energy and Enbridge.

Programs and Services

Programs emphasize technology validation, intellectual property management, and startup acceleration, leveraging expertise from offices like University of Toronto Innovations & Partnerships Office, McMaster Industry Liaison Office, and Western University Industry Liaison Office. Services include licensing support, business development, regulatory strategy referencing agencies such as Health Canada, U.S. Food and Drug Administration, and European Medicines Agency, and access to incubators and accelerators modeled after Y Combinator, Startupbootcamp, MassChallenge, and regional programs like Communitech and Velocity. Entrepreneurial training draws on curricula from Rotman School of Management, Schulich School of Business, Ivey Business School, Desautels Faculty of Management, and research commercialization frameworks used by Khosla Ventures and Sequoia Capital. Commercial translation assistance connects researchers to clinical trial networks such as ClinicalTrials.gov, funding pipelines like Mitacs, Canada Foundation for Innovation, and corporate development teams from Eli Lilly and Company and Bayer.

Partnerships and Collaborations

Partnership networks span universities, hospitals, investors, and corporations. Academic partners include Ryerson University (Toronto Metropolitan University), McGill University, Dalhousie University, University of British Columbia, and Université de Montréal. Hospital and research partners feature Toronto Western Hospital, Scarborough Health Network, Hamilton Health Sciences, and research institutes such as Cancer Research UK and Dana–Farber Cancer Institute. Industry collaborations have involved Roche Diagnostics, Medtronic, Siemens Healthineers, GE Healthcare, Philips, Baxter International, 3M, and Bristol Myers Squibb. Investment partnerships and syndicates include BDC Capital, Real Ventures, ScaleUP Ventures, Golden Ventures, iNovia Capital, and family offices connected to Maple Leaf Sports & Entertainment. International collaborative efforts reference entities like European Investment Bank, Asian Development Bank, World Bank Group, and philanthropic partners including Wellcome Trust and Bill & Melinda Gates Foundation.

Notable Technologies and Spin-offs

Spin-outs and licensed technologies have originated from research on diagnostics, therapeutics, and devices with associations to research groups at Princess Margaret Cancer Centre, SickKids Research Institute, Krembil Research Institute, Lunenfeld-Tanenbaum Research Institute, and faculty labs tied to Donnelly Centre for Cellular and Biomolecular Research. Notable alumni companies and technologies cite market engagement with firms like BlueRock Therapeutics, Spin Master, Zymeworks, RepliCel Life Sciences, Aurora Cannabis, and clinical device firms collaborating with Intuitive Surgical. Development pathways have engaged contract research organizations such as ICON plc, PPD, Inc., Parexel, and diagnostics developers working with Abbott Diagnostics and Roche Diagnostics.

Funding and Financial Model

The funding model combines equity stakes, licensing revenues, project-based grants, and partnerships with public and private funders including Ontario Ministry of Research and Innovation, Canada Economic Development for Ontario Regions, Strategic Innovation Fund, Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, Mitacs, and philanthropic contributions from organizations like Michael Smith Foundation for Health Research and Canadian Cancer Society. Capital formation has involved venture capital firms such as OMERS Ventures, Relay Ventures, Real Ventures, and corporate venture arms like Pfizer Ventures and Novartis Venture Fund, as well as impact investors and angel networks such as AngelList and Keiretsu Forum.

Category:Technology transfer organizations